The frequency of high PD-L1 expression is low in lung adenocarcinoma patients from Northeast Brazil

Volume: 2, Issue: 1, Pages: 1 - 6
Published: Dec 1, 2019
Abstract
As Immune checkpoint inhibitors (ICPIs) are changing the standard-care in lung cancer with good clinical activities and durable responses, its indication must be based on the appropriate patient selection once only a fraction of patients has a response to these costly drugs. In larger cohorts the expression of programmed cell death–ligand 1 (PD-L1) has been associated with good clinical response of ICPIs in lung adenocarcinoma where the rate of...
Paper Details
Title
The frequency of high PD-L1 expression is low in lung adenocarcinoma patients from Northeast Brazil
DOI
Published Date
Dec 1, 2019
Journal
Volume
2
Issue
1
Pages
1 - 6
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.